This study will build on our previous work concerning the phenomenology and classification of schizophrenia. Its basic and primary aim is to explore and develop new approaches to the classification of schizophrenia that unite neurobiological, phenomenological, longitudinal, and etiological aspects of the disorder. We postulate that the schizophrenic syndrome is heterogeneous and that it includes a spectrum of disorders. In this proposal, we will examine 60 first-episode patients drawn from the schizophrenia spectrum and 90 """"""""young chronic"""""""" patients (patients under 30 years of age who have been ill less than five years). These subjects will be drawn from the entire schizophrenia spectrum. They will be evaluated at baseline with a comprehensive clinical assessment, indicators of motor function (smooth pursuit eye movements and finger tapping), neuropsychological assessment, and magnetic resonance imaging. Thereafter they will be followed at six-month intervals in order to identify predictors of outcome and indicators of good vs. poor prognosis. We also propose to explore the heterogeneity of schizophrenia by examining at least fifteen multiplex families. We have identified approximately five such families in which at least two members suffer from schizophrenia. The assessment of these family members will include evaluation, including psychometric measures of schizotype in addition to clinical evaluation, magnetic resonance imaging, neuropsychological evaluation, and smooth pursuit eye movements. Detailed birth history will also be obtained. The study will permit us to evaluate the schizophrenia spectrum and to explore the possibility that this spectrum of disorders represents an additive accumulation of multiple risk factors that determine the clinical presentation of the disorder. A final aspects of the study involves instrument development. In addition to the Scale for the Assessment of Negative Symptoms (SANS) and the Scale for the Assessment of Positive Symptoms (SAPS), which are now widely used, we have developed a full interview for the assessment of schizophrenia and affective disorders, the Comprehensive Assessment of Symptoms and History (CASH). We propose extensive reliability and validity studies using this instrument.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37MH031593-14
Application #
2244310
Study Section
Special Emphasis Panel (NSS)
Project Start
1979-01-01
Project End
1998-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
14
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Iowa
Department
Psychiatry
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Rudd, Danielle S; Axelsen, Michael; Epping, Eric A et al. (2014) A genome-wide CNV analysis of schizophrenia reveals a potential role for a multiple-hit model. Am J Med Genet B Neuropsychiatr Genet 165B:619-26
Onwuameze, O E; Nam, K W; Epping, E A et al. (2013) MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse. Psychol Med 43:619-31
Salinas, Joel; Mills, Elizabeth D; Conrad, Amy L et al. (2012) Sex differences in parietal lobe structure and development. Gend Med 9:44-55
Wassink, Thomas H; Epping, Eric A; Rudd, Danielle et al. (2012) Influence of ZNF804a on brain structure volumes and symptom severity in individuals with schizophrenia. Arch Gen Psychiatry 69:885-92
Pierson, Ronald; Johnson, Hans; Harris, Gregory et al. (2011) Fully automated analysis using BRAINS: AutoWorkup. Neuroimage 54:328-36
Ho, Beng-Choon; Andreasen, Nancy C; Ziebell, Steven et al. (2011) Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 68:128-37
Ho, Beng-Choon; Wassink, Thomas H; Ziebell, Steven et al. (2011) Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr Res 128:66-75
Andreasen, Nancy C; Pressler, Marcus; Nopoulos, Peg et al. (2010) Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 67:255-62
Ho, Beng-Choon; Magnotta, Vincent (2010) Hippocampal volume deficits and shape deformities in young biological relatives of schizophrenia probands. Neuroimage 49:3385-93
Hartz, Sarah M; Ho, Beng-Choon; Andreasen, Nancy C et al. (2010) G72 influences longitudinal change in frontal lobe volume in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 153B:640-647

Showing the most recent 10 out of 206 publications